Endogenously labeled thyroid hormones (131I-T3/T4) in sera of patients with differentiated thyroid carcinoma

Thyroid

Volumn 6, Issue 3, 1996, Pages 201-206

  Lukinac, Ljerka ^a   Franceschi, Maja ^a   Nöthig Hus, Dunja ^a   Lechpammer, Stanislav ^a   Tomašic, Jelka ^b   Vranešić, Branka ^b   Pape, Ervin ^a   Kusić, Zvonko ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROID HORMONE;

ADULT; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID HORMONE BLOOD LEVEL; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADULT; CARCINOMA; CHROMATOGRAPHY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; THYROGLOBULIN; THYROID NEOPLASMS; THYROXINE; TRIIODOTHYRONINE;

EID: 0029738232     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Maxon HR III, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endo Metab Clin North Am 19:685-718.
2. Franceschi M, Kusić Z, Franceschi D, Lukinac Lj, Rončević S 1996 Thyroglobulin determination, neck ultrasonography and 1-131 whole body scintigraphy in the follow-up of patients with differentiated thyroid carcinoma. J Nucl Med 37:446-451.
3. Franceschi M, Kusić Z, Lukinac Lj, Rončević S, Labar Ž, Franceschi D 1992 Thyroglobulin determination, Tl-201 scintigraphy and neck ultrasonography in the follow-up of patients with DTC. Eur J Nucl Med 19:700.
4. Bianchi R, lervasi G, Matteucci F, et al. 1993 Chromatographic identification in serum of endogenously radioiodinated thyroid hormones after iodine-131 whole-body scintigraphy in the follow-up of patients with differentiated thyroid carcinoma. J Nucl Med 34:2032-2037.
5. 131I thyroxin and thyroid cancer. Thyroid 4:195-198.
6. 4 in the follow-up of a patient with papillary cancer. Proceedings of the Laboratory Medicine '95 at the 11th IFCC European Congress of Clinical Chemistry, Tampere, Finland, July 2-7 (Abstract 736).
7. Langsteger W, Koltringer P, Wolf G, et al. 1993 The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. Eur J Cancer 29A:1547-1553.
8. Fagin JA 1994 Molecular pathogenesis of human thyroid neoplasms. Thyroid Today 17:1-7.
9. 131I in the treatment of thyroid cancer. Thyroid Today 16:1-9.
10. Kusić Z, Lechpammer S, Daković N, et al. 1994 Radioiodine therapy for distant metastases in well differentiated thyroid cancer. Tur J Nucl Med 3:Abs 30.
11. Robbins J 1994 Approaches to the treatment of high-risk thyroid cancer. Thyroid 4:385-387.
12. Dralle H 1993 Metaanalysis of thyroid cancer risk in patients with cold thyroid nodules and multinodular goiter. Exp Clin Endocrinol 101:109-117.
13. Sherman SI, Tielens ET, Sostre S, et al. 1994 Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 78:629-634.
14. Schlumberger M, Fragu P, Gardet P, et al. 1991 A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. Eur J Nucl Med 18:153-157.
15. Heinze HG, Rall M 1992 The value of the new IRMA for determining thyroglobulin. Nuklearmedizin 31:172-177.
16. 3 by metastases of a thyroid carcinoma. Acta Endocrinol Copenh 127:413-415.